This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Patisaul, H. B. Articles by Young, L. J. Search for Related Content PubMed PubMed Citation Articles by Patisaul, H. B. Articles by Young, L. J.

Soy Isoflavone Supplements Antagonize Reproductive Behavior and Estrogen Receptor - and ß-Dependent Gene Expression in the Brain¹

Center for Behavioral Neuroscience (H.B.P., P.L.W., L.J.Y.) and Departments of Anthropology (P.L.W.) and Psychiatry and Behavioral Sciences (L.J.Y.), Emory University, Atlanta, Georgia 30329

Address all correspondence and requests for reprints to: Dr. Heather B. Patisaul, Center for Behavioral Neuroscience, Emory University, 954 Gatewood Road NE, Atlanta, Georgia 30329.

Epidemiological evidence suggests that isoflavone phytoestrogens may reduce the risk of cancer, osteoporosis, and heart disease, effects at least partially mediated by estrogen receptors and ß (ER and ERß). Because isoflavone dietary supplements are becoming increasingly popular and are frequently advertised as natural alternatives to estrogen replacement therapy, we have examined the effects of one of these supplements on estrogen-dependent behavior and ER- and ERß-dependent gene expression in the brain. In the adult female rat brain, 17ß-estradiol treatment decreased ERß messenger RNA signal in the paraventricular nucleus by 41%, but supplement treatment resulted in a 27% increase. The regulation of ERß in the paraventricular nucleus is probably via an ERß-dependent mechanism. Similarly, in the ventromedial nucleus of the hypothalamus, supplement treatment diminished the estrogen-dependent up-regulation of oxytocin receptor by 10.5%. The regulation of oxytocin receptor expression in the ventromedial nucleus of the hypothalamus is via an ER-dependent mechanism. Supplement treatment also resulted in a significant decrease in receptive behavior in estrogen- and progesterone-primed females. The observed disruption of sexual receptivity by the isoflavone supplement is probably due to antiestrogenic effects observed in the brain. These results suggest that isoflavone phytoestrogens are antiestrogenic on both ER- and ERß-dependent gene expression in the brain and estrogen-dependent behavior.